This article surveys the current general understanding of genetic influences on within-and between-population variation in growth and development in the context of establishing an International Growth Standard for Preadolescent and Adolescent Children. Traditional genetic epidemiologic analysis methods are reviewed, and evidence from family studies for genetic effects on different measures of growth and development is then presented. Findings from linkage and association studies seeking to identify specific genomic locations and allelic variants of genes influencing variation in growth and maturation are then summarized. Special mention is made of the need to study the interactions between genes and environments. At present, specific genes and polymorphisms contributing to variation in growth and maturation are only beginning to be identified. Larger genetic epidemiologic studies are needed in different parts of the world to better explore population differences in gene frequencies and gene-environment interactions. As advances continue to be made in molecular and statistical genetic methods, the genetic architecture of complex processes, including those of growth and development, will become better elucidated. For now, it can only be concluded that although the fundamental genetic underpinnings of the growth and development of children worldwide are likely to be essentially the same, there are also likely to be differences between populations in the frequencies of allelic gene variants that influence growth and maturation and in the nature of gene-environment interactions. This does not necessarily preclude an international growth reference, but it does have important implications for the form that such a reference might ultimately take.
Introduction
The aim of this paper is to provide a brief overview of traditional relative-based genetic epidemiologic analysis methods and to describe the findings from a sampling of studies that have quantified in some manner the contribution of genetic influences to variation in common measures of normal growth and development. This paper does not include discussion of genetically determined clinical growth disorders. Sources of systematic variation in human growth (e.g., secular trends and socioeconomic influences on growth) is discussed by Ulijaszek [1] in this supplement. Specifically, this paper focuses on current general understanding of genetic influences on within-and between-population variation in growth and development so that this knowledge can be considered in the broader discussion of the feasibility of establishing an international growth reference.
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methodological issues pertaining to the assessment of morphological, skeletal, and sexual maturity characteristics during prepubertal and pubertal growth.
Methods for assessing genetic influences on growth and development Familial correlations and heritability estimation
Two major study designs are typically used to initially quantify genetic and environmental influences on measures of growth and development: twin studies and family studies. In most modern twin studies, both monozygotic (MZ) and dizygotic (DZ) twins are examined. Since MZ twins have an identical genetic makeup, they will be more similar (i.e., exhibit a higher intrapair correlation) in a trait (that is under at least some genetic control) than DZ twins, who share on average half of their genes (as do full siblings from singleton births). When twin data are used, genetic influences, as well as environmental influences both unique to the individual and shared within families, can be identified, as can, when certain assumptions are made, dominant genetic effects.
In family studies, patterns of similarities in a trait among parents and offspring, siblings, and other pairings of relatives are evaluated. This approach allows for the quantification of genetic and nongenetic sources of variation in a trait (including specifically identified nongenetic sources of variation). If data from combined pedigrees (e.g., twins and their parents) or extended families (e.g., grandparents, children, and grandchildren) are available, more sophisticated models can be tested, because such data are from relatives of varying degrees of relationship to each other and who span multiple generations and, oftentimes, households. Detailed discussion of analysis of twin and family data be found in basic texts (e.g., Neale and Cardon [9] ).
Regardless of study design, the resulting heritability (h 2 ) of a trait is the key first step toward understanding the nature of genetic influences on a trait. Detailed discussion of quantitative genetic analysis can be found in basic textbooks [10, 11] . Briefly, the heritability of a trait is a measure of the extent to which the variation observed in a trait can be ascribed to genetic factors, ranging from 0% (no genetic effects) to 100% (complete genetic control). Assessment of heritability is based initially on a simple quantitative genetic model in which the total variation (V P ) in a trait is partitioned into genetic (V G ) and environmental (V E ) variance components such that V P = V G +V E . Broad-sense heritability specifically refers to the proportion of the total phenotypic variation that can be attributed to all genetic effects (primarily consisting of additive, dominance, and epistatic effects) as defined by V G /V P (i.e., h 2 = V G /V P ). The variance term V G can be decomposed into an additive genetic term (V A ) that refers to the additive effects of genes across several genetic loci, a dominance S259 term (V D ) that refers to the interaction between alleles at the same locus (i.e., the heterozygote effect is not intermediate between the two homozygote genotype effects), and an epistasis term (V I ) that refers to the interaction between alleles at different loci. Narrowsense heritability specifically refers to the proportion of the total phenotypic variation that can be attributed only to the additive effects of one or more genes at one or more chromosomal locations (i.e., V A ) and is defined as h 2 = V A /V P . In most instances, heritability estimates refer to narrow-sense heritabilities. Generally speaking, narrow-sense heritability is of more utility in characterizing genetic influences on continuously distributed traits such as various measures of growth and development. Variation in such traits is probably influenced by a number of genes, each with small to moderate effects. In this variance components framework, the environmental variance term V E can similarly be decomposed into components due to, for example, environmental factors shared by certain family members (e.g., common household environment or specific aspects thereof) and/ or components due to environmental factors specific to the individual (e.g., behaviors or habits unique to certain family members).
The quantitative genetic models of sources of variation outlined above make several assumptions that may or may not be realistic, depending upon the particular study population and traits being examined. These assumptions include no gene-environment interaction (i.e., different genotypes all react equally to environmental factors), no gene-environment correlation (i.e., different genotypes are distributed equally across different environments), no gene-gene interaction (i.e., a genotype at one locus that contributes to variation in a trait has no influence on the effect that a genotype at another locus might have on variation in that same trait), and no assortative mating (i.e., people mate randomly with respect to the phenotype in question). Violation of these assumptions does not invalidate the fundamental approach (such violations may or may not be significant in magnitude) but requires that caution be used in interpreting results. It must also be kept in mind that heritabilities are population-level estimates, specific to a particular population in a particular environment, and this can sometimes be an important consideration when heritability estimates across populations are compared. For example, differences in heritability estimates in groups from different ethnic backgrounds, of different socioeconomic status, or from affluent versus developing countries can be indicative of differences in the relative importance of genetic and environmental factors in different circumstances [12, 13] . For example, Luke et al. [14] found significant differences among Nigerian, Jamaican, and US blacks in the heritability of adult height (h 2 = .62, .74, .87, respectively), although they did not speculate as to the reasons for these differences. In that same study, obesity-related phenotypes showed large differences in the prevalence of obesity (5.4% in Nigerians, 23.3% in Jamaicans, and 39.0% in US blacks), but their heritability estimates did not differ among the three groups. In general, heritability estimates for various traits, including measures of growth and development, tend to be robust and generally similar across populations.
Incorporation of environmental factors into genetic analyses
Because of significant differences between populations in lifestyle (e.g., diet and physical activity), environmental exposures (e.g., disease), and evolutionary histories (e.g., different selective pressures), gene-environment interactions merit special attention in the study of genetic influences on growth and development. Gene-environment interaction is probably an important influence on the variation observed among children in their growth and development, particularly in populations exposed to environmental factors known to negatively impact health. The key to gene-environment interaction is that not all children may respond to the same degree to such environmental factors, and a portion of that differential response may be due to genetic variation among them.
The study of gene-environment interaction effects on complex traits using modern molecular and statistical genetic methods, however, is still in its infancy, and is likely to constitute a major component of genetic epidemiologic research for decades to come. To study gene-environment interaction effects on growth and development requires data from a large number of related children who are exposed to an environmental factor shown to, on average, negatively (or positively) impact health. Although the principles of gene-environment interaction have been empirically demonstrated in a number of experimental organisms, and in a few instances in studies of humans using identical twin study designs, study of gene-environment interaction effects on the growth and development of children usually requires taking advantage of particular circumstances.
For example, in the Jiri Growth Study [15, 16] , a cohort of more than 1,000 related children from the Jirel ethnic group in rural eastern Nepal, where intestinal helminthic infections are endemic, are being examined annually. Data collected include an extensive battery of anthropometrics, skeletal age assessments, and quantification of parasite burden. The central hypothesis of the Jiri Growth Study is that susceptibility to helminthic infections is genetically mediated and that this, in turn, contributes to patterns of variation observed among children in different measures of their growth and development. Similarly, the rapid increase in childhood overweight and obesity, particularly in developed nations, offers researchers opportunities for the study of gene-environment interactions. The vast majority of children in developed nations live in environments
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where food is plentiful and relatively inexpensive. For reasons that have yet to be fully explored, however, not all children partake equally in this abundance. And, even among children who equally overindulge in this modern bounty, it is reasonable to hypothesize that there are differential responses in terms of weight gain and other measures of health status.
Linkage and association studies
As it has become well established that essentially all commonly collected measures of growth and development have significant and substantial genetic underpinnings, attention in the postgenomic era has turned to the identification of specific genes that influence variation in those measures. Linkage analysis and association studies are two complementary strategies [17] used to identify genes that explain a portion of the variability in complex traits, including measures of growth and development.
Linkage analysis is an important initial tool for the mapping of genetic loci harboring genes that influence the trait of interest. In a modern whole genome linkage scan, related individuals are genotyped for several hundred highly variant DNA markers whose exact chromosomal locations are known and that are regularly spaced throughout the genome (e.g., every 10 centimorgans). Different approaches to linkage analysis exist [17] , but the fundamental premise of any linkage analysis is that two loci physically close to each other on a chromosome are likely to be inherited together. As the distance between loci increases, the likelihood that these loci will cross over or recombine during meiosis (and thus not be inherited together) also increases. Loci close to each other on a chromosome are referred to as being linked. Loci harboring genes that influence variation in quantitative traits such as stature, weight, and the timing and tempo of growth are called quantitative trait loci (QTL). Linkage between a QTL and a marker exists when pairs of relatives who are more phenotypically similar share more alleles at a particular marker locus than pairs of relatives who are more phenotypically dissimilar.
The second approach to gene identification is association studies [17] . In association studies, the effect of a specific (polymorphic) marker allele (typically within a candidate gene) on variation in a trait is measured. For example, a study sample is divided into two or more groups on the basis of marker genotype, and differences between the groups in the trait being examined are evaluated by statistical tests such as analysis of variance (ANOVA). Testing for significant differences in marker allele frequencies in a case-control design can also be conducted. In this case, the test is for whether or not there are significant differences in marker allele frequencies between an "affected" group and a "control" group. As in linkage studies, in association studies the markers used may be single tandem repeat markers (STRs) or single nucleotide polymorphisms (SNPs) and can also include insertion/deletion polymorphisms or multiallelic variants. When a significant association is found (e.g., more girls with an early age at menarche being found to have a particular marker genotype than random expectation), the putative "early menarche" allele under study might be a true functional variant (e.g., resulting in an amino acid change in protein structure) or might be in linkage disequilibrium with the true functional allele (i.e., tending to be inherited together with the functional allele). As knowledge of the human genome has progressed, multiple polymorphisms within one or more genes, or even genomewide, can now be studied. Here, instead of testing for association with each polymorphism separately, haplotypes (e.g., a set of SNPs along a region of a chromosome) can be tested for patterns of association with variation in the trait of interest.
Linkage and association studies are best viewed as being complementary to each other, or as different steps in the systematic intellectual endeavor of proceeding from observing variation in a trait to identifying the functional genetic determinants contributing to that variation [15, 18, 19] . Association studies have appeal because data from unrelated individuals can be used (however, family data can be included in the analyses to overcome problems of hidden population stratification, which can increase the finding of false positive associations). Unfortunately, the success of candidate gene association studies in identifying specific polymorphisms influencing complex traits has been decidedly mixed. Current genome-wide association studies hold promise, using SNP (single nucleotide polymorphism) microarray chips with up to 500,000 variants to densely cover the genome, but present their own set of problems (e.g., multiple testing). Linkage studies require data from (ideally) a large number of relatives to provide adequate statistical power for establishing linkage, and the cost of genotyping each family member for approximately 400 genetic markers (for the typical 10-centimorgan map) can be high (although the cost of genotyping has markedly decreased over the last decade). Once such a familial study population is established, however, a wide variety of traits can be examined using that same resource. A current common strategy for genetic epidemiologic studies of normal variation in complex traits proceeds from heritability estimation, to linkage analysis, to fine mapping, to sequencing, to final identification of a functional genetic polymorphism. Association studies in larger samples can then proceed in an informed manner to evaluate the effects of specific genes on the trait of interest in different populations. At each step in this modern process, the effects of covariates and of various types of interactions can be incorporated into the analyses. A shortcut to this stepwise procedure is to find specific candidate genes for growth-related S261 phenotypes. These can come from whole-genome gene expression studies (mRNA levels in tissue), although this might be unrealistic to perform because of the nature of the sampling procedures needed to obtain growing tissue material (e.g., bone, growth plate, muscle, and fat) in children and adolescents. Differences in up-or down-regulation of genes in growing tissue versus adult tissue might also be informative for the specific genes involved in regulating individual differences in growth. Candidate genes might also be detected from gene effects on growth and development in rodent or other animal models that might have similar effects in growing children.
Evidence for genetic effects on growth and development Familial correlations and heritabilities
The literature on familial or genetic contributions to variation in measures of normal growth and maturation is fairly extensive and dates back almost a century. On the basis of that body of work, it is well established that genes play a major, if not the major, role in explaining variation observed among children in their growth and development, even in poor environments.
Stature, weight, and patterns of growth
Stature. Estimates of the contribution of genetic factors to interindividual differences in adult height have recently been reviewed [12, 20] . Detailed reviews of genetic influences on the growth and development of children have been published by Maes [21] and more recently by Towne et al. [15] .
In general, in populations around the world, h 2 estimates of height range from 0.6 to more than 0.9, clearly showing that height is a highly heritable trait. Intrapair correlations for the recumbent lengths of MZ and DZ twins at birth are similar, which also suggests the importance of shared environmental factors (i.e., maternal and intrauterine factors) in contributing to the length of newborns. The similarities between MZ twins increase from 3 months until they reach a stable and high level of similarity at 3 years of age and onward. In DZ twins, the high similarity observed at birth decreases to a value approximately half that of MZ twins by the age of 3 years. Data on adult height from large twin cohorts of whites in eight developed countries show that although there are differences in population averages in adult height, in general only minor differences in the genetic architecture of height are present [20] . Although heritability estimates might be comparable in affluent populations, Mueller et al. [22] compared 24 studies of parent-child correlations and found that population estimates of heritability tend to be systematically lower in developing countries than in developed countries. Part of this observation might be explained by higher nutritional and disease stresses in non-European populations in the developing world. Such environmental factors have the potential to negatively affect growth, thereby increasing the environmental variance and thus reducing the estimate of heritability. Rapid and recent economic change in developing countries also creates different growth environments for children and their parents, thereby decreasing parent-child correlations and thus reducing the estimate of total variation attributable to genes. More recent studies of adult height in rapidly developing countries report h 2 estimates more similar to those that have typically been reported for the adult height of individuals in developed countries. For example, Li et al. [23] reported an estimated h 2 of 0.647 (±0.122) in a Chinese population, and Arya et al. [13] reported an h 2 of 0.72 in an Indian population. Whether lower heritability estimates are due to a larger absolute contribution of environmental variance, increasing the total variability and therefore lowering the h² estimate, or to a lower absolute contribution of genetic variance (in the case of an equal total variation) is not easily verifiable, since most studies do not report the variance components, but only the relative contribution of genetic factors (h²).
Weight. In general, genetic determination of normal body weight is somewhat lower than that of height. This is probably because body weight is more susceptible to environmental influences such as dietary intake and energy expenditure. Estimates of the h 2 of body weight vary considerably from 0.20 to about 0.90. As for height, generally lower h 2 estimates for body weight in developing countries are probably due primarily to nutritional and disease stress and to differences in environmental conditions for children and their parents.
Patterns of growth. Analysis of genetic influences on patterns of growth requires longitudinal familial data so that individual growth curves can be fitted and parameters quantifying the timing and magnitude of growth over time derived. Such data are much rarer than cross-sectional data from unrelated children, but the data that do exist reveal many interesting findings. For example, differences between ethnic groups in patterns of growth have been found, indicating a role for genetic factors (and/or different environmental factors). Murata and Hibi [24] found an earlier occurrence of the adolescent growth spurt in Asian populations than in Caucasian populations. In meta-analyses of European and US growth studies, Hermanussen et al. [25] , however, found that there were no major differences in growth patterns between populations in these countries and that the patterns have remained fairly similar during the twentieth century, despite a striking increase in mean body height, suggesting that individuals from populations with similar ethnic backgrounds are generally similar in their patterns of growth.
Lower sibling and twin correlations during puberty (for girls around 11 to 13 years and for boys around 13 S262 to 15 years of age) are more marked for DZ twins than for MZ twins, suggesting that not only height but also the timing of the height spurt is under genetic control [26, 27] . Differences in the individual timing of the growth spurt make twins less similar when studied cross-sectionally at the same chronological ages during puberty.
Other studies have specifically estimated the h 2 of different growth curve parameters (see table 2 ). For example, in the Leuven Longitudinal Twin Study, the Preece-Baines model I was applied to semiannual measurements of stature in 99 pairs of twins aged 10 to 18 years [28] . Parameters of the pubertal growth spurt were derived, including the timing (i.e., age), the magnitude (i.e., velocity), and stature at the prepubertal nadir of growth (i.e., just prior to takeoff of the adolescent growth spurt) and at the peak of pubertal growth. In addition, the percentage of adult stature at both the prepubertal nadir of growth and the peak of pubertal growth and the predicted adult stature were derived. A model including additive genetic and specific environmental variance components in males and females best explained most of the variation observed in the growth parameters. For the timing and velocity of the adolescent growth spurt, no sex heterogeneity was observed, and the genetic (0.89 to 0.93) and specific environmental (0.07 to 0.11) contributions were equal in both sexes. The small sex differences could be explained by overall differences in total variance between the velocities of growth at takeoff and at PHV. Parameters pertaining to percentage of adult stature, or distance to grow from prepubertal takeoff or age at PHV, however, indicated a different set of genes to be active in males and females. Beunen et al. [28] reported a significant component of nongenetic familial resemblance (0.39 to 0.56) for the attained height at PHV and for predicted adult height. In the Fels Longitudinal Study, nontransmissible sibling resemblance was also present for age at PHV in boys and for stature at takeoff of pubertal growth and at PHV in girls [29] .
Heritability estimates for the timing of the adolescent growth spurt in Swedish and Polish twins range from 0.49 to 0.76, except for PHV in Swedish girls [26, 30] . Within-pair growth curve similarities were higher in Swedish MZ twins (r = 0.85) than in DZ twins (r = 0.54) [31] . Intrapair correlations from MZ and DZ twins in the Wraclow twins and Swedish twins indicate lower heritability estimates for the timing of peak growth in weight and peak weight velocity, although substantial genetic factors seem to remain important [26, 32] .
Towne et al. [33] used a simple three-parameter function to fit individual growth curves to serial recumbent length data from 569 infants aged from birth to 2 years from nuclear and extended families in the Fels Longitudinal Study. Substantial h² estimates of 0.83 for recumbent length at birth, 0.67 for rate of increase in length, and 0.78 for a parameter describing the curvilinear shape of growth in recumbent length from birth to 2 years were found. In addition, genotype-by-sex (GxS) interaction was indicated for the latter two growth parameters, suggesting that the genes influencing rate of growth and intrinsic rate of change in growth are influenced by the sex of the individual. In a subsequent multivariate quantitative genetic analysis of the pubertal growth spurt, Towne et al. [34] used a triple logistic model to fit individual growth curves to serial stature data from 471 Fels Longitudinal Study participants aged 2 to 22 years. Highly significant h² estimates were found for age at PHV (0.85), growth rate at PHV (0.61), and stature at age of PHV (0.96). Additive genetic correlations between these growth-spurt parameters were all lower than 1.0, indicating that the timing of the pubertal growth spurt, its magnitude, and attained stature at the time of PHV are controlled by genes with partial pleiotropic effects.
Longitudinal genetic model-fitting can also be applied to serial data to examine the nature of genetic and environmental effects over time during childhood growth (i.e., testing whether or not genetic or environmental influences remain constant or change during growth). For example, in a sample of Swedish female twins, Fischbein found significant and similar genetic contributions to weight over the delimited age range of 11.5 to 14 years of age and only modest evidence for age-specific genetic influences on growth [35] . Another approach is to fit latent growth-curve models to longitudinal data and estimate the genetic and environmental contributions to the underlying latent growth-curve parameters simultaneously with the time-point-specific variation not explained by the growth curve. Peeters et al. [36, 37] * tested several underlying growth curves to longitudinal data of height and body weight of the Leuven Longitudinal Twin Study. Variance and covariance between Preece-Baines I curve parameters (timing and tempo of growth) was best explained by shared additive genetic factors and unique environmental factors, with slightly higher values for height than for weight. Genetic variation in the underlying growth curve was the most important source of variance to explain the overall variation in longitudinal growth in height and weight (h² above 0.90 in height and above 0.80 in weight).
Unfortunately, longitudinal familial data from populations in developing countries are scarce. Sibling similarity in annual growth increments in a small sample of schoolchildren aged 6 to 13 years from a subsistence agricultural community in Oaxaca, Mexico, were negative or close to zero (44 brother-brother, 44 sistersister, and 110 unlike-sex pairs). The lack of similarity between siblings in annual growth increments perhaps * Peeters M, Thomis 
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reflects age-specific variation in a genotype-environment interaction with chronic undernutrition, the important mediating environmental variable [38] . Many more such studies are needed, however, before any definitive statements can be made regarding crosspopulation differences in genetic influences on patterns of growth.
Skeletal maturation
Koniarek [39] determined skeletal age and skeletal maturation scores using the Tanner-Whitehouse (TW2) method in 55 pairs of male MZ and 55 pairs of male DZ twins, and 47 pairs of female MZ and 43 pairs of DZ twins, followed longitudinally in the Wroclaw twin study. The mean intrapair difference in skeletal maturity score was considerably lower for MZ twins of both sexes than for DZ twins across the age range of 7 to 18 years. Similarly, the standard deviation of the intrapair difference was also much smaller for MZ twins than for DZ twins. The highest intrapair differences were found in the period of 12 to 14 years in males and 9 to 13 years in females. The h 2 of skeletal age at the onset of menses in these female twins was estimated at 85% [40] . In a multivariate longitudinal analysis of Wroclaw Twin Study data, evidence was found for highly integrated genetic processes underlying both growth in stature and skeletal maturation, which have a different timing in boys and girls, relating to different effects of estrogen and testosterone/androgens in the stimulation of linear growth and acceleration or deceleration of bone maturation [41] .
These findings are in concordance with those obtained in analyses of skeletal ages at the chronological ages of 3, 6, 9, 12, and 15 years, as determined by the Fels method [7] , from 742 subjects, in 124 to 172 families in the Fels Longitudinal Study [42] . All available patterns of familial resemblance across relatives of varying degrees of relationships are taken into account to estimate the heritability of skeletal age at these five ages from late infancy to postpuberty. The h 2 of skeletal age was highest at 3 and 6 years of age (h 2 = ~1.00 and 0.97, respectively) and decreased to 0.48 by 15 years.
The genetic correlations between skeletal ages closely positioned in time (e.g., at 3-year intervals) were high (> 0.84) and decreased with increasing time intervals (e.g., at 6-year intervals they ranged from 0.56 to 0.73, and at 9-year intervals they ranged from 0.30 to 0.37) and were lowest at the 12-year interval (0.16). These results indicate that although there are some genetic influences on skeletal maturation that appear to act throughout childhood, there are also some genetic influences that are more time-delimited in their action. Skeletal maturation is a complex process, and different biological phenomena occur at different stages of development. Early childhood is predominantly a time of bone ossification; in mid-childhood there are changes in bone shape and joint formation; and in puberty epiphyseal fusion begins to take place. Structural genes might be responsible for the appearance of bones and subsequent changes in their shape, whereas regulatory genes (e.g., hormones) may influence more the tempo of skeletal maturation.
At 10 and 13 years, the Tanner-Whitehouse II-20 scores in twins from the Leuven Longitudinal Twin Study (20 to 25 pairs of twins in five twin-by-sex zygosity groups) were highly determined by genetic factors. At 10 years, h² = 0.92 and e² = 0.08; at 13 years, h² = 0.88 and e² = 0.12. Sex differences in the variability of Tanner-Whitehouse II-20 scores at the chronological age of 13 years could be attributed to a general scalar effect [43] .
In a recent preliminary analysis of skeletal maturation in Nepali children participating in the Jiri Growth Study, the h 2 of tempo of skeletal maturation from middle to late childhood (chronological ages 6 to 18 years) was high at 0.92 [44] .
Sexual maturation
Age at menarche. Menarche is the hallmark maturational event of female puberty, and many studies have shown the timing of the onset of the menses to be significantly influenced by genetic factors (see Towne et al. [45] for a recent review). For example, MZ female twin correlations for age at menarche are high (0.65 to 0.90) Genetic determinants of growth and development S264 [40, 46] , with DZ twin correlations ranging from 0.16 to 0.60. Sibling correlations are generally around 0.40 [47] , and mother-daughter correlations generally range from 0.24 to 0.39 [47] [48] [49] [50] [51] . The mean difference in age at menarche is smallest for MZ twins (0.4 years), with increasing mean intrapair differences for DZ twins (0.8 years), siblings (1 year), and mother-daughter pairs (1.1 year). Some studies report high heritability estimates for this sexual maturation milestone (h² = 0.95), with evidence for dominance effects (d² = 0.54, a² = 0.17) [46] , or shared genetic effects with skeletal maturity (h² unique to age at menarche = 0.44, h² shared with skeletal maturity = 0.53) [40] . More recent reports using prospective age at menarche data and larger kinship data report h 2 estimates around 0.50 [45] . Genital development and secondary sexual characteristics. Data from the Wroclaw Longitudinal Twin Study show a higher concordance between MZ males for genital developmental stages (G2 to G5) and pubic hair development stages (PH2 to PH5) than between DZ males [52] ; similarly, MZ females are more concordant than DZ females for stages of breast and pubic hair development [53] .
Linkage and association studies
To date, relatively few modern whole-genome scans searching for QTL influencing measures of normal growth and development have been conducted. Such linkage studies pose logistic and financial challenges, since familial data must be collected and extensive marker genotyping must be carried out. There are many more studies of associations between polymorphic markers in candidate genes and measures of growth and development. This is because data from related individuals are not necessarily needed, and only one or a few markers need to be genotyped. Unfortunately, the results of association studies are very often equivocal and contradictory. There are many possible reasons for this, the primary ones being small sample sizes, unaccounted-for population stratification, and the unpredictable nature of disequilibrium between the genotyped marker and the functional polymorphism influencing the trait of interest [54] . In the future, whole-genome association mapping studies using tens of thousands of genetic markers may be used to discover functional polymorphisms related to complex traits, including measures of human growth and development.
Linkage results
Stature. Most whole-genome linkage scans on growth and development measures have been done on adult stature. This is primarily because adult stature is often self-reported in large, questionnaire-based, genetically oriented population studies (e.g., families, twin registries), and because stature was one of the earliest phenotypes for which a large genetic component was observed (from twin and family studies). There are few linkage studies of height or weight phenotypes in the preadolescent and adolescent period, because there exist few studies of genetically related individuals in which sufficient data have been collected from them during their childhood.
A recent study reporting identification of QTLs for height in a Dutch sibling-pairs study also reviews linkage results for adult stature in other populations [55] . Adult stature, with a Gaussian distribution, is a multifactorial trait, and genetic influence on it is probably due to the cumulative effects of allelic variants at several loci. Significant linkage LOD scores (i.e., LOD scores > 3.0) and suggestive LOD scores (i.e., minimum LOD scores > 1.0) are spread at 92 locations over 21 chromosomes. Regions on chromosomes 3, 6, (harboring estrogen receptor alpha), 7, 12, 13, and 14 show the highest linkage peaks (LOD scores > 3.0). In a small sample of 79 sibling pairs, significant linkage (p = .004) was found between a dinucleotide marker in the dopamine 2 receptor gene and height in 79 sibling pairs aged 7 to 18 years [56] .
Hirschhorn et al. [57] explored the differences in linkage results (especially lack of replication) from four different populations (Botnia, Finland; Finland; Southern Sweden; and Sagueney-Lac-St. Jean, Quebec). From simulation studies, they concluded that these differences could be due to sampling variation only, but that population-specific differences in the occurrence of rare or common alleles or differences in linkage disequilibrium patterns could also contribute to the different results. Population-specific interactions with other genes or environmental factors need to be taken into account when different linkage peaks are reported in different populations.
Göring et al. [58] conducted whole-genome scans using data from European-American, Mexican-American, European, and Nepali populations and found suggestive evidence of linkage of adult height to several genomic regions. The linkage signals were not, however, necessarily consistent across the study populations, suggesting that the importance of individual candidate loci may vary in different populations.
The major fraction of variation observed in the stature of healthy individuals is suggested as being determined by autosomal genes, and the contribution of sex-linked genes, if any, is small [59] . Sex chromosomes do, however, have a fundamental role in setting the stage for growth [60] , as can be observed in patients with sex chromosome aberrations. Growth retardation is observed in Turner's syndrome (X-linked), whereas for GCY (growth control gene) on Yq, a 9-cm increase in adult height is found independently of gonadal sex steroids [61] .
Weight and body-mass index. Because of the relevance of adiposity to type 2 diabetes, cardiovascular S265 disease, and other disorders related to overweight and obesity, many linkage analyses of overweight, obesity, and other measures of adiposity have been conducted in recent years (see Perusse et al. [62] for a recent review). Virtually all of these studies, however, have been conducted on adults or have included children with adults in the analyses. Moreover, the focus is often more on phenotypes at the higher end of the distribution of overweight and obesity and less on the full range of normal variability in body weight. This situation is likely to change in coming years, however, as specific childhood precursors of adult disease risks come under closer scrutiny. A significant part of this endeavor will include searching for genes influencing childhood normal weight and overweight and other adiposity traits.
For example, Arya et al. [63] recently conducted a whole-genome scan for QTL influencing birthweight in Mexican-Americans and non-Hispanic Whites. In a sample of Mexican-Americans from San Antonio, Texas, they found significant evidence of linkage of birthweight to a QTL on chromosome 6q (LOD = 3.72). In a sample of non-Hispanic whites participating in the Fels Longitudinal Study, strongly suggestive evidence of linkage of birthweight to a QTL at the same location on chromosome 6q also was found (LOD = 2.84). This study not only provides replication of a significant linkage finding for a QTL on chromosome 6q for birthweight, but also provides evidence that this chromosome 6q QTL influences the intrauterine growth of children from two different ethnic backgrounds. In 782 randomly ascertained white siblings (521 full-sib pairs and 39 half-sib pairs) in the Bogalusa Heart Study, linkage results from a genome scan on longitudinal analysis of body-mass index (BMI) changes from childhood to young adulthood (area-under-the-curve analysis) indicated suggestive signals for linkage with regions on chromosomes 1, 5, 7, 12, 13, and 18 [64] . Several of these regions have been found to be significantly linked to body weight or obesity measures in studies of adults.
Skeletal maturation. In the Fels Longitudinal Study, skeletal ages were determined for 1,069 children, aged 1 to 17 years, from 220 families (9,865 total assessments of skeletal age) by the use of the Fels method [7] . An initial set of 478 subjects was genotyped for approximately 400 autosomal markers. Variance components-based linkage analysis (SOLAR) [65] found consistent evidence of a QTL on chromosome 8q that influences skeletal age at chronological ages 2 to 10 years (LOD scores ranged from 0.96 to 3.16 at wholeyear intervals over this age range). Suggestive evidence of linkage of skeletal age at various chronological ages to markers on other chromosomes also was found. This unique linkage study of longitudinal skeletal age data found evidence of specific QTL containing as yet unidentified genes that influence the tempo of normal skeletal maturation during different stages of childhood development.
In recent analysis of data collected from Nepali children participating in the Jiri Growth Study, Towne et al. [44] recently found significant linkage (LOD = 3.32) of the tempo of skeletal maturation during middle and late childhood (ages 6 to 18 years) to genetic markers on chromosome 3p. Interestingly, in a recent bivariate linkage analysis of second metacarpal cortical bone thickness and skeletal age in a set of 600 10-year-olds from the Fels Longitudinal Study, Duren et al. [66] found significant joint linkage of both traits to the same location on chromosome 3p. Together, these two studies provide some confirmatory evidence of a gene or genes on chromosome 3p that influence skeletal maturation and bone growth during middle childhood in children from two very different populations.
Results of association studies
Reports on associations of allelic variants with growth in height, weight, and maturity characteristics are mainly focused on variations in genes coding for growth hormones, growth hormone receptors, and bone metabolism-related genes (table 3) . There is only limited information on associations of gene polymorphisms with indicators of the timing and tempo of growth or other maturity characteristics. Furthermore, as often observed with association studies, there is a lack of consistency in the results, with only limited replication of findings. For the purposes of this chapter, a literature search using MEDLINE was performed combining the terms "height, weight, maturity, menarche, sexual maturation" with the terms "association, polymorphism" and "childhood, adolescent, growth. "
Height and growth curve characteristics. In 183 male and 131 female participants in the Fels Longitudinal Study, pubertal growth parameters were estimated by the triple logistic method as implemented in the AUXAL program [5] . In boys, ESRa PvuII and XbaI polymorphisms were significantly associated with the timing of the prepubertal nadir of growth, height at the prepubertal nadir, and height at the age of PHV. For the PvuII polymorphism, boys homozygous for the rarer allele (pp) were 0.6 years younger (p = .0035) and 5.7 cm shorter (p = .0026) at the prepubertal nadir than heterozygous boys (Pp) or boys homozygous for the more common allele (PP). They were also 0.6 years younger (p = .0088) and 5.4 cm shorter (p = .0023) at the peak of the pubertal growth spurt. As adults, pp genotype males were 4.8 cm shorter (p = .01) than those with the PP genotype. In girls these trends were generally evident but were not as statistically significant. For example, height at PHV in girls with the pp genotype differed by 2.0 cm from that in girls with the PP genotype (p = .047), and the mean adult height of Genetic determinants of growth and development S266 Tao et al. [69] wt, wild type; vt, variant type a. Genes are listed in alphabetical order of their symbols females with the pp genotype was 2.5 cm shorter than that of females with the PP genotype. There was no effect of the XbaI polymorphism in ESRa on pubertyrelated growth parameters in either sex [67] . Lorentzon et al. [68] also had observed a similar trend for adolescent Caucasian boys with the ESRa PvuII pp genotype to be shorter than PP boys at 16.9 ± 0.3 years, and they observed no effects of the XbaI genotype. However, no effect of the ESRa PvuII genotype on height or weight was found in 7-year-old Caucasians in a small study by Tao et al. [69] . Vitamin D receptor (VDR) polymorphisms have been studied extensively in relation to bone mineral content and density in relation to osteoporosis and bone accretion during growth. Some studies have related variation in the VDR gene to characteristics of preadolescent growth and found that associations with Bone mineral density (BMD)/bone mineral content (BMC) disappeared after correction for size differences. In the sample studied by Tao et al. [69] , females homozygous for a TaqI polymorphism in the vitamin D receptor gene (TT) were 4.1 cm taller and 3.9 kg heavier than those with the Tt or tt genotype.
Possible interactions between estradiol receptor gene (ER . PvuII) and VDR (BsmI, BB or bb) polymorphisms have been studied by Suarez et al. [70] in 161 healthy Caucasian full-term babies. There was a lack of association between ER polymorphisms and body weight in boys and girls, body length in girls, or body length in boys with a bb genotype. However, the ER polymorphism and body length were significantly associated in BB boys, with a smaller length at birth and at age 10 months (but not at 2 years of age) for those with a BBpp genotype. An association between stature and a putative functional polymorphism in the promoter region of the dopamine 2 receptor gene (DRD2) was examined in the 79 sibling pairs aged 7 to 18 years and in 125 unrelated male Japanese adults. The association with stature (p = .009, paired t-test, in the sibling pairs; p = .006, ANOVA, in the adults) was suggestive of a role of the DRD2 promoter polymorphism in stature [56] .
Raivio et al. [71] studied two point mutations in the ß-subunit of the luteinizing hormone-beta gene (LH-ß) in a group of 49 healthy boys followed from a mean age of 11.7 years at 3-month intervals. Thirty-six boys (74%) were homozygous for the wild-type LH-ß allele, 12 (24%) were heterozygous carriers of the variant allele, and 1 (2%) was homozygous for the variant allele. Boys with the variant allele were shorter (p < .02), had slower growth rates (p < .04), and had lower serum insulin-like growth factor I-binding protein-3 levels (p < .03) than boys homozygous for the wild-type LH-ß allele. In boys with delayed onset of puberty, the frequency of the variant LH-ß allele did not differ from that in the reference population, indicating that the variant allele is not associated with conditions due to Genetic determinants of growth and development S272 disturbed control of the reactivation of GnRH secretion. During the progression of puberty, the variant LH-ß allele may be less active in stimulating testicular growth than the wild-type LH-ß allele. Thus, the gene may affect tempo, contributing to the wide normal variation in pubertal progression in healthy boys. Similar findings were observed in US boys and girls in the Fels Longitudinal Study, but the association between the variant LH-ß allele and height during puberty was not as pronounced as in the sample of Finnish boys [72] .
Weight. As mentioned earlier, identifying specific genes influencing weight, overweight or obesity, and other measures of adiposity is of relevance for understanding genetic influences on adiposity-related measures of diabetes and cardiovascular disease risks, both in childhood and during adulthood. Although greater attention should be paid to genetic variation in normal weight for developing an International Growth Standard for Preadolescent and Adolescent Children, several studies have examined associations between polymorphisms in candidate genes and measures of body mass and adiposity in overweight or obese children, and these are of interest given the worldwide increase in obesity in both children and adults. For example, in a sample of Italian children, Lucarini et al. [73] found an association between BMI and a marker in the acid phosphatase-1 (ACP1) gene on chromosome 2p. In a sample of Japanese children, Endo et al. [74] found an association between BMI and a polymorphism in the beta-3-adrenergic receptor (ADRB3) gene on chromosome 8p. In a Chinese sample, Xinli et al. [75] found an association between body weight in obese children and a polymorphism in the ADRB3 gene. In a sample of German children, however, no associations between obesity and polymorphisms in the ADBR1, ADBR2, or ADBR3 genes were found [76] . In a sample of US children, Gelernter-Yaniv et al. [77] found an association between a polymorphism in the 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene on chromosome 1q and BMI, waist circumference, and waist-hip ratio. In a German study, Roth et al. [78] reported transmission disequilibrium and sequence variants of the leptin receptor (LEPR) gene on chromosome 1p in a sample of extremely obese children. Hinney et al. [79] found evidence of association between polymorphisms in the melanocortin-4-receptor (MC4R) gene on chromosome 18q and extreme obesity in a sample of German children. In a Finnish study, Karvonen et al. [80] found an association between a polymorphism in the preproneuropeptide Y (NPY) gene on chromosome 7p and birthweight. Hung et al. [81] found evidence of associations between polymorphisms in the small heterodimer partner (SHP) gene on chromosome 1p and birthweight and adiposity during childhood. Tremblay et al. [82] found an association between a polymorphism in the glucocorticoid receptor (GRL) gene on chromosome 5p and increase in adiposity in girls from adolescence to young adulthood.
Age at menarche. Only a few polymorphisms have been associated with age at menarche, and there is a lack of replication in different samples or populations. Because early age at menarche is a risk factor for the development of breast cancer, many genes involved in breast cancer have been studied, and some are related to age at menarche (however, these breast cancer gene polymorphisms have not been included systematically in this review).
In addition to pubertal growth, as discussed earlier, associations between the PvuII (P/p) and XbaI (X/x) polymorphisms in the ESRa gene and age at menarche have also been studied. In a closed rural community in northwestern Greece, the PvuII and XbaI haplotype was significantly related to a later age at menarche (homozygous PPXX versus all other haplotypes: 13.43 ± 1.18 years versus 12.76 ± 1.25 years) [83] . However, in a study of 90 girls (mean age, 15.6 years), the PvuII and XbaI haplotype was not related to age of menarche [84] . Furthermore, no association was found in 317 Japanese women [85] . These authors, however, report a significant association of age at menarche with the MspAI polymorphism in the CYP17 gene, one of the estrogen-metabolizing genes (estrogen biosynthesis, P450c17a). Women with higher CYP17 activity (A2/A2 and A1/A2 genotypes) tended to have an earlier age at menarche (13.6 ± 1.2 years) than women with lower CYP17 activity (A1/A1 genotype; 14.1 ± 1.3 years) [85] . Similar findings for a later age at menarche for A1/A1 genotypes were found in women without breast cancer [86] . Polymorphisms in the hydroxylation (cytochrome P4501A; CYP1A1) gene and the gene regulating inactivation of the reactive metabolites (catechol-Omethyltransferase; COMT) were not associated with age at menarche in these Japanese women [85] . In a mixed ethnic sample of 583 women, however, age at menarche was not significantly related to the CYP17 polymorphism nor to polymorphic variants of the CYP3A4, CYP1B1, and CYP1A2 genes [87] . NOS3 gene variants (Glu298Asp, T-786C, repeat in intron 4) were studied in 87 to 91 Austrian women, although no significant association with age at menarche could be found [88] . The vitamin D receptor gene VDR (ApaI polymorphism) was significantly related to an earlier age at menarche (12.1 versus 12.5 years) in 120 Japanese 18-to 19-year-old females [89] .
Recently, more evidence has been found for the role of the leptin gene in the regulation of onset of puberty. Leptin gene variation (LEP D7S1875, < 280 bp versus ≥ 280 bp) has been shown to have opposite effects on age at menarche, depending on maternal age at the time of delivery of the girls under study [90] . In mothers giving birth to their daughters before the age of 30 years, the longer allele of the LEP D7S1875 polymorphism was associated with an earlier age at menarche in the daughters in comparison with heterozygotes S273 and homozygotes of the short alleles. In contrast, for maternal ages ≥ 30 years, daughters with the ≥ 280 bp/≥ 280 bp genotype had a later age at menarche. A 10-bp insertion in the 5' end of the gonadotropinreleasing hormone receptor (GnRHR) gene was not associated with age at menarche in 196 Japanese girls aged 18 to 20 years [91] . Within the androgen receptor gene, a GGC repeat polymorphism (16 repeats versus polymorphisms with other repeat numbers) has been associated with an earlier age at menarche for 16 GGC repeat carriers as compared with genotypes with other repeat numbers [92] .
A recent report by Sedlmeyer et al. [93] searched for sequence variation in both GnRHR and GnRH1 in males and females with late maturity onset (children with late maturity and their parents (UK and US sample) and in an association sample of 506 females from the US Multiethnic Cohort Study of Diet and Cancer. Haplotype block analyses were performed, as well as htSNPs analysis within the detected haplotype blocks. The authors concluded that the studied haplotypes and htSNPs within GnRHR and GnRH1 seemed to have only limited influence on the timing of puberty.
Breast development. The onset of breast development (≥ T2B stage versus T1B) could be predicted from CYP3A4*B1 variant genotypes in 9.5-year-old girls [94] ; the B1 variant is associated with the onset of T2B. The onset of breast development was not associated with gene variants in other estrogen-metabolizing genes (CYP17, CYP1A1, CYP1A2, CYP1B1, and CYP3A5) [94] .
Testicular volume. In their study of association between a variant of the LH-ß allele and pubertal growth of Finnish boys discussed earlier, Raivio et al. [71] also found that boys with the variant LH-ß allele had smaller testicular volumes (p < .03) than boys homozygous for the wild type LH-ß allele.
As the above discussion has pointed out, association studies have tested the significance of gene sequence variants in several genes in relationship to height, weight, and other maturity-related phenotypes. However, studies on children and adolescents in developing countries are lacking, and there is limited replication of findings. The degree of replication might even be underestimated because of positive publication bias; negative association results (i.e., showing lack of association) might not be published as often as positive association findings. Therefore, we do not have sufficient information to state that there are large population differences in the effects of specific gene variants, and whether this might be due to differences in the amount of the gene effect, differences in population-specific allele frequencies, or the contribution of different genes.
Conclusions
In the wake of the profound advances made in molecular and statistical genetic techniques and methods over the last two decades, advances that continue to be made at a rapid pace, the genetic architecture of complex processes such as those that constitute growth and development will become better elucidated in the coming years. Much of this better understanding of genetic influences on growth and maturation will be motivated by increasingly recognized associations between patterns of growth and the development of disease risks during adulthood. As alluded to in the forgoing sections of this chapter, there are two particular areas of research on the nature of genetic influences on growth and maturation that pertain directly to the broader issue of the establishment of an International Growth Standard for Preadolescent and Adolescent Children. These are population differences in major gene effects on growth and maturation, and the effect of gene-environment interactions on growth and maturation.
Population differences in major gene effects on growth
As yet there are too few cross-population genetic epidemiologic studies of growth and maturation to arrive at any definitive conclusions on this matter. Nonetheless, populations differ in gene frequencies, and it is reasonable to hypothesize that there are differences across populations in the frequencies of specific alleles that influence growth and development. This has implications for the relative importance of such specific genetic influences on growth and development in different populations. Allelic variation in a particular growth-related gene may explain a significant part of the observed variation in a measure of growth in one population but not necessarily in another. This does not mean that the fundamental genetic architecture of growth and development differs across populations, but that the relative importance of specific genes and their allelic variants might well differ across populations. Furthermore, the issue of nonreplication should be judged carefully. As mentioned earlier, in a series of simulations, Hirschhorn et al. [57] found that lack of replication in linkage studies across populations (for a true QTL explaining 20% of the trait variance) could be due simply to sampling variation.
Effects of gene-gene and gene-environment interactions
As stated earlier, gene-environment interaction effects are not easily studied, and the nature of gene-environment interaction effects across populations are complicated and difficult to assess. At present, there is very little knowledge about the effects of gene-environment interactions on height, weight, and maturity-related characteristics in children and adolescents. Large population-based studies in different areas of the world will Genetic determinants of growth and development S274 be needed to study the interaction of an individual's genotype with environmental factors, which can be beneficial (e.g., nutritional balance, physically active lifestyle) or harmful (e.g., nutritional imbalance, disease and illnesses, war, sedentary lifestyle) to the growing child. Because environmental factors, as well as the frequencies of pertinent alleles, might differ greatly between populations, the impact of gene-environment interaction on the observed variation in the growth and maturation of children across populations can be hypothesized to be significant. Knowledge of gene variants found to be protective against harmful environmental factors can be highly informative for the detection of children at risk for their individual response to those environmental factors (e.g., at risk for the development of obesity).
Implications for an international growth standard for preadolescent and adolescent children
The preceding discussion makes it clear that there is much that is as yet unknown regarding the nature of cross-population differences in genetic influences on growth and maturation. This gap in knowledge necessitates that caution be taken in the consideration of an International Growth Standard for Preadolescent and Adolescent Children, but it does not necessarily preclude the establishment of such a reference. Nonetheless, to reiterate two related points: » Genetics plays a leading role in explaining individual variation within populations in growth and development traits, but there might be population differences in the genetic regulation of growth and development that have yet to be fully examined. » It can reasonably be hypothesized that although the fundamental genetic underpinnings of the growth and development of children worldwide may be essentially the same, there may be differences between populations in the nature of gene-by-environment interactions.
As with any population-specific growth reference, the development of a single international growth standard for preadolescent and adolescent children will need to reflect both average growth and normal variation in growth. This should not pose an insurmountable problem, since most of the observed differences in complex quantitative traits such as measures of growth and development are probably contained within any sufficiently large group of subjects from within a population [95, 96] . Thus, the challenges are to determine what data should contribute to an International Growth Standard for Preadolescent and Adolescent Children, determine the form that this standard should take, and finally to determine whether the form that an international growth standard for preadolescent and adolescent children ultimately takes will prove useful in day-to-day application in different parts of the world.
As environmental sources of variation that negatively impact growth and maturation (e.g., disease and malnutrition) are ameliorated in developing nations, it will become somewhat easier to evaluate the nature of population variation in genetic influences on growth and maturation. It is reasonable to hypothesize that population differences in measures of growth and maturation may become smaller in the coming decades, but at the same time it is also reasonable to hypothesize that a genetic basis to population differences in measures of growth and development will remain, and that these will become primary sources of interpopulation differences in measures of growth and maturation. Such population differences will need to be accommodated in an International Growth Standard for Preadolescent and Adolescent Children.
One option for an International Growth Standard for Preadolescent and Adolescent Children, then, would be to create "median" values in growth for children and adolescents from many populations worldwide who are growing up in more or less environmentally ideal, or at least suitable, situations (e.g., balanced diet, regular exercise, peaceful home and social life, lack of major illnesses, lack of pollution, etc.). A list of known growth disorders with a genetic etiology also would need to be used as exclusion criteria. Overall variation in stature and other measures from such data would be almost entirely a reflection of population-specific genetic variation, population-specific environmental variation, and population-specific gene-environment interactions, which individually or collectively may or may not be large contributors to mean interpopulation differences in measures of growth.
In the application of an International Growth Standard for Preadolescent and Adolescent Children, there may need to be a paradigm shift among researchers and clinicians from thinking of specific height-for-age values in terms of percentiles to thinking in terms of a percentile ranking that consists of a range of potential values. Of course, if the range of values at any particular age becomes too large, then the utility of such a growth reference is compromised.
In conclusion, this review has summarized the current general understanding of genetic influences on within-and between-population variation in growth and development. As was discussed, almost all measures of growth and development have substantial and significant genetic underpinnings. But although major progress has been made in both molecular genetic and statistical genetic techniques over the last quarter-century, many questions remain unanswered and need further study. There is a need for more genetic epidemiologic studies of the growth and development of children from non-Western populations in order to better understand population differences in the genetic regulation of processes of growth and maturation, as well as to study specific gene-environment interactions and their effects on growth and development. A S275 variety of research designs can be used to contribute to this knowledge. An international growth standard for preadolescent and adolescent children will need to be particularly mindful of potentially significant differences between populations in the genetic regulation of growth and development that may exist even after detrimental environmental factors have been ameliorated.
